{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:27:23Z","timestamp":1793766443171,"version":"4.6.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clgc.2026.102636","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:11:10Z","timestamp":1785341470000},"page":"102636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Impact of Initial Management Strategies in Metachronous Oligometastatic Renal Cell Carcinoma: A Real-World Evidence"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8908-0817","authenticated-orcid":false,"given":"Chiara","family":"Re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3515-483X","authenticated-orcid":false,"given":"Ciro","family":"Piccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7109-2429","authenticated-orcid":false,"given":"Antonio","family":"Cigliola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cosenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4987-7898","authenticated-orcid":false,"given":"Alessandro","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6024-7177","authenticated-orcid":false,"given":"Giacomo","family":"Musso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7872-0257","authenticated-orcid":false,"given":"Lucia","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Disabato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1165-1776","authenticated-orcid":false,"given":"Chiara","family":"Mercinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigida","family":"Maiorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1199-2338","authenticated-orcid":false,"given":"Valentina","family":"Tateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Deantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7006-8196","authenticated-orcid":false,"given":"Cesare","family":"Cozzarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Di Muzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Larcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Rosiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3007-2756","authenticated-orcid":false,"given":"Andrea","family":"Necchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9225-1795","authenticated-orcid":false,"given":"Umberto","family":"Capitanio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clgc.2026.102636_bib0001","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/ijc.35278","article-title":"The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide","volume":"156","author":"Filho","year":"2025","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.clgc.2026.102636_bib0002","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.eururo.2025.06.005","article-title":"Epidemiology of renal cancer: incidence, mortality, survival, genetic predisposition, and risk factors","volume":"88","author":"Larcher","year":"2025","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102636_bib0003","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102636_bib0004","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clgc.2026.102636_bib0005","article-title":"European Association of Urology guidelines on renal cell carcinoma: the 2025 update","volume":"25","author":"Bex","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2026.102636_bib0006","unstructured":"Motzer RJ, Jonasch E, Agarwal N, et al. NCCN Clinical Practice Guidelines in Oncology: Kidney Cancer. Version 3.2025. National Comprehensive Cancer Network; 2025. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1440. Accessed August 18, 2026."},{"issue":"9286","key":"10.1016\/j.clgc.2026.102636_bib0007","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0140-6736(01)06103-7","article-title":"Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial","volume":"358","author":"Mickisch","year":"2001","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.clgc.2026.102636_bib0008","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMoa003013","article-title":"Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer","volume":"345","author":"Flanigan","year":"2001","journal-title":"New Engl J Med"},{"issue":"3","key":"10.1016\/j.clgc.2026.102636_bib0009","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3390\/cancers15030793","article-title":"Complete response in metastatic clear cell renal cell carcinoma patients treated with immune-checkpoint inhibitors: remission or healing? How to improve patients' outcomes?","volume":"15","author":"Thouvenin","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.clgc.2026.102636_bib0010","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jamaoncol.2023.7266","article-title":"Charting the path to systemic therapy de-escalation-oligometastatic kidney cancer as a paradigm","volume":"10","author":"Tang","year":"2024","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102636_bib0011","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.juro.2016.07.079","article-title":"Outcomes following complete surgical metastasectomy for patients with metastatic renal cell carcinoma: a systematic review and meta-analysis","volume":"197","author":"Zaid","year":"2017","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.clgc.2026.102636_bib0012","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.euo.2018.08.028","article-title":"Surgical metastasectomy in renal cell carcinoma: a systematic review","volume":"2","author":"Ouzaid","year":"2019","journal-title":"Eur Urol Oncol"},{"issue":"13","key":"10.1016\/j.clgc.2026.102636_bib0013","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/cncr.25836","article-title":"Survival after complete surgical resection of multiple metastases from renal cell carcinoma","volume":"117","author":"Alt","year":"2011","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.clgc.2026.102636_bib0014","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/JU.0000000000000488","article-title":"Complete surgical metastasectomy of renal cell carcinoma in the post-cytokine era","volume":"203","author":"Lyon","year":"2020","journal-title":"J Urol"},{"issue":"12","key":"10.1016\/j.clgc.2026.102636_bib0015","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/S1470-2045(21)00528-3","article-title":"Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial","volume":"22","author":"Tang","year":"2021","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102636_bib0016","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.euo.2022.06.008","article-title":"Stereotactic ablative radiation for systemic therapy-na\u00efve oligometastatic kidney cancer","volume":"5","author":"Hannan","year":"2022","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2026.102636_bib0017","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.semradonc.2021.02.002","article-title":"Stereotactic ablative radiation (SAbR) for oligometastatic RCC","volume":"31","author":"All","year":"2021","journal-title":"Semin Radiat Oncol"},{"issue":"9","key":"10.1016\/j.clgc.2026.102636_bib0018","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S1470-2045(16)30196-6","article-title":"Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial","volume":"17","author":"Rini","year":"2016","journal-title":"Lancet Oncol"},{"issue":"13","key":"10.1016\/j.clgc.2026.102636_bib0019","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/cncr.33494","article-title":"Active surveillance of metastatic renal cell carcinoma: results from a prospective observational study (MaRCC)","volume":"127","author":"Harrison","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2026.102636_bib0020","article-title":"State of the art: multidisciplinary management of oligometastatic renal cell carcinoma","volume":"43","author":"Dason","year":"2023","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"6","key":"10.1016\/j.clgc.2026.102636_bib0021","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.euo.2025.01.007","article-title":"Towards a consensus on the management of metastatic renal cell carcinoma: insights from a European delphi study","volume":"8","author":"Albiges","year":"2025","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"10.1016\/j.clgc.2026.102636_bib0022","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/JU.0000000000001911","article-title":"Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I","volume":"206","author":"Campbell","year":"2021","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.clgc.2026.102636_bib0023","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.clgc.2022.03.013","article-title":"Impact of metastasectomy on cancer specific and overall survival in metastatic renal cell carcinoma: analysis of the REMARCC registry","volume":"20","author":"Meagher","year":"2022","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2026.102636_bib0024","article-title":"SABR for oligometastatic renal cell carcinoma","volume":"45","author":"David","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.clgc.2026.102636_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2025.12.007","article-title":"Stereotactic radiation for systemic therapy-na\u00efve oligometastatic kidney cancer: final results of a phase 2b trial","author":"Hannan","year":"2026","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2026.102636_bib0026","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.clgc.2021.05.004","article-title":"Active surveillance in metastatic renal cell carcinoma: results from the Canadian kidney cancer information system","volume":"19","author":"Kushnir","year":"2021","journal-title":"Clin Genitourin Cancer"},{"issue":"15","key":"10.1016\/j.clgc.2026.102636_bib0027","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa2312695","article-title":"Overall survival with adjuvant pembrolizumab in renal-cell carcinoma","volume":"390","author":"Choueiri","year":"2024","journal-title":"N Engl J Med"},{"issue":"10358","key":"10.1016\/j.clgc.2026.102636_bib0028","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0140-6736(22)01658-0","article-title":"Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial","volume":"400","author":"Pal","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clgc.2026.102636_bib0029","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/KCA-240006","article-title":"Post-metastasectomy adjuvant therapy in patients with renal cell carcinoma: a systematic review","volume":"8","author":"Monda","year":"2024","journal-title":"Kidney Cancer"},{"issue":"2","key":"10.1016\/j.clgc.2026.102636_bib0030","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.clgc.2024.01.021","article-title":"The impact of a multidisciplinary tumor board (MTB) on treatment decision making for patients with renal cell carcinoma (RCC): 5-year data analysis","volume":"22","author":"Brink","year":"2024","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"10.1016\/j.clgc.2026.102636_bib0031","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13073-020-00723-8","article-title":"Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors","volume":"12","author":"Smith","year":"2020","journal-title":"Genome Med"},{"issue":"12","key":"10.1016\/j.clgc.2026.102636_bib0032","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.annonc.2025.08.007","article-title":"Circulating kidney injury molecule-1 (KIM-1) and association with outcome to adjuvant immunotherapy in renal cell carcinoma","volume":"36","author":"Rini","year":"2025","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2026.102636_bib0033","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.euo.2020.12.011","article-title":"Novel liquid biomarkers and innovative imaging for kidney cancer diagnosis: what can Be implemented in our practice today? A systematic review of the literature","volume":"4","author":"Campi","year":"2021","journal-title":"Eur Urol Oncol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326001369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326001369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:15:38Z","timestamp":1793765738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767326001369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1558767326001369"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102636","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Impact of Initial Management Strategies in Metachronous Oligometastatic Renal Cell Carcinoma: A Real-World Evidence","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102636","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102636"}}